Registry analysis explores real-world use of aflibercept 8 mg in diabetic macular edema

Results of a registry analysis on the real-world use of aflibercept 8 mg in treatment-naive and previously treated eyes with diabetic macular edema were presented at the American Society of Retina Specialists annual meeting.“This is a registry study [on Eylea HD (aflibercept 8 mg, Regeneron)], so we don’t have individual patient-level data, and unfortunately, at this time, we